中国浸润性乳腺癌诊治临床实践指南(2022版)

2022-01-30 中华医学会外科学分会乳腺外科学组 中国实用外科杂志

乳腺癌是我国女性最常见的恶性肿瘤,发病率呈逐年上升趋势,手术、放疗、系统治疗相结合的综合治疗模式极大地改善了乳腺癌病人的生存及预后,其中手术治疗依旧占据非常重要的地位。

中文标题:

中国浸润性乳腺癌诊治临床实践指南(2022版)

发布日期:

2022-01-30

简要介绍:

乳腺癌是我国女性最常见的恶性肿瘤,发病率呈逐年上升趋势,手术、放疗、系统治疗相结合的综合治疗模式极大地改善了乳腺癌病人的生存及预后,其中手术治疗依旧占据非常重要的地位。乳腺外科医师不仅需要掌握娴熟的手术技巧,同时应具备乳腺癌病人全程管理和综合治疗的能力。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国浸润性乳腺癌诊治临床实践指南(2022版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=ba5e41c0023a83a4, title=中国浸润性乳腺癌诊治临床实践指南(2022版), enTitle=, guiderFrom=中国实用外科杂志, authorId=0, author=, summary=乳腺癌是我国女性最常见的恶性肿瘤,发病率呈逐年上升趋势,手术、放疗、系统治疗相结合的综合治疗模式极大地改善了乳腺癌病人的生存及预后,其中手术治疗依旧占据非常重要的地位。, cover=https://img.medsci.cn/202229/1644411830460_5579292.png, journalId=0, articlesId=null, associationId=2134, associationName=中华医学会外科学分会乳腺外科学组, associationIntro=中华医学会外科学分会乳腺外科学组 , copyright=0, guiderPublishedTime=Sun Jan 30 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">乳腺癌是我国女性最常见的恶性肿瘤,发病率呈逐年上升趋势,手术、放疗、系统治疗相结合的综合治疗模式极大地改善了乳腺癌病人的生存及预后,其中手术治疗依旧占据非常重要的地位</span><span style="color: #333333;">。乳腺外科医师不仅需要掌握娴熟的手术技巧,同时应具备乳腺癌病人全程管理和综合治疗的能力。</span></p>, tagList=[TagDto(tagId=13575, tagName=浸润性乳腺癌), TagDto(tagId=117297, tagName=妇瘤乳腺肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5457, appHits=247, showAppHits=0, pcHits=784, showPcHits=5210, likes=3, shares=45, comments=16, approvalStatus=1, publishedTime=Thu Feb 10 15:01:00 CST 2022, publishedTimeString=2022-01-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Feb 09 21:06:52 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 11:53:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国浸润性乳腺癌诊治临床实践指南(2022版).pdf)])
中国浸润性乳腺癌诊治临床实践指南(2022版).pdf
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1231547, encodeId=1c39123154e83, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f75f1625151, createdName=15119b8c1fm, createdTime=Sat Jul 09 21:35:09 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200021, encodeId=bbdf1200021c7, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:21:47 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200017, encodeId=2bd8120001efb, content=实用,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:18:38 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199353, encodeId=0982119935371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bc5255114, createdName=AK柳叶刀, createdTime=Fri Mar 04 11:42:02 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197962, encodeId=f7a8119e962bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220228/eb147544b77b47e9afbd77e33830a7bc/bc03e3a115da4efcb27cabdb226c708b.jpg, createdBy=2ef06526945, createdName=ms8000001600527708, createdTime=Mon Feb 28 10:44:55 CST 2022, time=2022-02-28, status=1, ipAttribution=)]
    2022-07-09 15119b8c1fm

    实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1231547, encodeId=1c39123154e83, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f75f1625151, createdName=15119b8c1fm, createdTime=Sat Jul 09 21:35:09 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200021, encodeId=bbdf1200021c7, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:21:47 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200017, encodeId=2bd8120001efb, content=实用,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:18:38 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199353, encodeId=0982119935371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bc5255114, createdName=AK柳叶刀, createdTime=Fri Mar 04 11:42:02 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197962, encodeId=f7a8119e962bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220228/eb147544b77b47e9afbd77e33830a7bc/bc03e3a115da4efcb27cabdb226c708b.jpg, createdBy=2ef06526945, createdName=ms8000001600527708, createdTime=Mon Feb 28 10:44:55 CST 2022, time=2022-02-28, status=1, ipAttribution=)]
    2022-03-06 ms6980619036574494

    实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1231547, encodeId=1c39123154e83, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f75f1625151, createdName=15119b8c1fm, createdTime=Sat Jul 09 21:35:09 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200021, encodeId=bbdf1200021c7, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:21:47 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200017, encodeId=2bd8120001efb, content=实用,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:18:38 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199353, encodeId=0982119935371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bc5255114, createdName=AK柳叶刀, createdTime=Fri Mar 04 11:42:02 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197962, encodeId=f7a8119e962bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220228/eb147544b77b47e9afbd77e33830a7bc/bc03e3a115da4efcb27cabdb226c708b.jpg, createdBy=2ef06526945, createdName=ms8000001600527708, createdTime=Mon Feb 28 10:44:55 CST 2022, time=2022-02-28, status=1, ipAttribution=)]
    2022-03-06 ms6980619036574494

    实用,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1231547, encodeId=1c39123154e83, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f75f1625151, createdName=15119b8c1fm, createdTime=Sat Jul 09 21:35:09 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200021, encodeId=bbdf1200021c7, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:21:47 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200017, encodeId=2bd8120001efb, content=实用,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:18:38 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199353, encodeId=0982119935371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bc5255114, createdName=AK柳叶刀, createdTime=Fri Mar 04 11:42:02 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197962, encodeId=f7a8119e962bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220228/eb147544b77b47e9afbd77e33830a7bc/bc03e3a115da4efcb27cabdb226c708b.jpg, createdBy=2ef06526945, createdName=ms8000001600527708, createdTime=Mon Feb 28 10:44:55 CST 2022, time=2022-02-28, status=1, ipAttribution=)]
    2022-03-04 AK柳叶刀

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1231547, encodeId=1c39123154e83, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f75f1625151, createdName=15119b8c1fm, createdTime=Sat Jul 09 21:35:09 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200021, encodeId=bbdf1200021c7, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:21:47 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200017, encodeId=2bd8120001efb, content=实用,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Sun Mar 06 21:18:38 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199353, encodeId=0982119935371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83bc5255114, createdName=AK柳叶刀, createdTime=Fri Mar 04 11:42:02 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197962, encodeId=f7a8119e962bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220228/eb147544b77b47e9afbd77e33830a7bc/bc03e3a115da4efcb27cabdb226c708b.jpg, createdBy=2ef06526945, createdName=ms8000001600527708, createdTime=Mon Feb 28 10:44:55 CST 2022, time=2022-02-28, status=1, ipAttribution=)]
    2022-02-28 ms8000001600527708

    学习

    0